Skip to main content

Advertisement

Table 1 Diabetic (n = 7) and non-diabetic (n = 7) patient characteristics and echocardiographic data

From: Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats

Parameter Non-diabetic patient Type 2 diabetic patient p-value
Age (years) 68.0 ± 2.0 65.2 ± 2.6 0.41
Sex 6 M, 1 F 6 M, 1 F n/a
BMI 28.3 ± 1.6 32.6 ± 2.4 0.14
HbA1C (%) 5.4 ± 0.2 7.4 ± 0.5 0.01*
HbA1C (mmol/mol) 36 ± 2 58 ± 6  
Glucose (mmol/L) 5.9 ± 0.3 8.1 ± 1.6 0.20
Duration of diabetes (y) 12.2 ± 2.3 n/a n/a
MAP (mmHg) 98.4 ± 5.3 n/a 0.91
Beta blockers 4/7 6/7 n/a
ACE inhibitors 6/7 5/7 n/a
LVEDV (mL) 88 ± 12 86 ± 8 0.89
LVESV (mL) 36 ± 6 35 ± 4 0.92
EF (%) 60 ± 2 60 ± 1 0.86
E vel (cm/s) 0.6 ± 0.1 0.7 ± 0.1 0.56
A vel (cm/s) 0.8 ± 0.1 0.9 ± 0.1 0.26
E/A 0.9 ± 0.1 0.8 ± 0.1 0.50
  1. Data are expressed ± SEM
  2. M male, F female, HbA1C glycated haemoglobin, MAP mean arterial blood pressure, LVEDV left ventricular end diastolic diameter, LVESV left ventricular end systolic diameter, EF ejection fraction
  3. For all parameters independent t-test, * p < 0.05